Published in J Med Chem on July 01, 1989
Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther (1969) 4.24
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed Proc (1987) 1.83
Dating the common ancestor of SIVcpz and HIV-1 group M and the origin of HIV-1 subtypes using a new method to uncover clock-like molecular evolution. FASEB J (2000) 1.78
Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity. Am J Surg Pathol (1993) 1.76
Purification and characterization of measles virus. J Gen Virol (1973) 1.71
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
Negative-pressure dressings as a bolster for skin grafts. Ann Plast Surg (1998) 1.60
Membrane proteins of subacute sclerosing panencephalitis and measles viruses. Nature (1978) 1.49
Measles-virus proteins in the brain tissue of patients with subacute sclerosing panencephalitis: absence of the M protein. N Engl J Med (1981) 1.48
Evidence for lack of synthesis of the M polypeptide of measles virus in brain cells in subacute sclerosing panencephalitis. Virology (1979) 1.48
mtDNA variation indicates Mongolia may have been the source for the founding population for the New World. Am J Hum Genet (1996) 1.44
Endoscopic harvest of the rectus abdominis muscle. Ann Plast Surg (2000) 1.41
Outcome of infants born to hepatitis C infected women. Ir J Med Sci (2001) 1.38
A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. QJM (2011) 1.38
Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat. Proc Soc Exp Biol Med (1973) 1.36
Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Proc Natl Acad Sci U S A (1991) 1.34
A strategy for rapid, high-confidence protein identification. Anal Chem (1997) 1.33
Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol (1976) 1.33
Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther (2004) 1.28
The biochemical and biological characteristics of the surface components of measles virus. J Gen Virol (1974) 1.28
6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir. Proc Natl Acad Sci U S A (1984) 1.25
Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci U S A (1999) 1.24
Aldehyde oxidase from rabbit liver: specificity toward purines and their analogs. Arch Biochem Biophys (1986) 1.20
Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci U S A (1990) 1.17
Xanthine oxidase from human liver: purification and characterization. Arch Biochem Biophys (1986) 1.17
Pathway of onset, development, and decay of carrageenan pleurisy in the rat. Fed Proc (1982) 1.16
Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up. Antivir Ther (2001) 1.14
Does earwax lose its pathogens on your auriscope overnight? BMJ (1993) 1.14
Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity. J Virol (1991) 1.10
In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med (1992) 1.08
RNA homology between subacute sclerosing panencephalitis and measles viruses. Nature (1976) 1.07
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. Proc Natl Acad Sci U S A (1995) 1.06
The functions and inhibition of the membrane glycoproteins of paramyxoviruses and myxoviruses and the role of the measles virus M protein in subacute sclerosing panencephalitis. J Infect Dis (1981) 1.02
Purification and properties of inosine-guanosine phosphorylase from Escherichia coli K-12. J Bacteriol (1988) 1.00
Aspirin-like drugs inhibit arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in rat neutrophils from carrageenan pleural exudates. Biochem Biophys Res Commun (1980) 0.99
Crystallization and preliminary X-ray investigation of uridine phosphorylase from Escherichia coli. J Biol Chem (1987) 0.98
Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol (1998) 0.98
Endemic human T cell leukemia virus type II infection in southwestern US Indians involves two prototype variants of virus. J Infect Dis (1993) 0.97
Structure and function relationships of the envelope of measles virus. Med Microbiol Immunol (1974) 0.97
Quantitative studies of the pathway to acute carrageenan inflammation. Fed Proc (1976) 0.97
Spontaneous production of C-C chemokines by individuals infected with human T lymphotropic virus type II (HTLV-II) alone and HTLV-II/HIV-1 coinfected individuals. J Immunol (2000) 0.96
Lack of evidence for the transmission of JC polyomavirus between human populations. Arch Virol (1997) 0.95
Defective interfering particles produced during the replication of measles virus. Med Microbiol Immunol (1974) 0.93
Potentiation of the anti-inflammatory and analgesic activity of aspirin by caffeine in the rat. Proc Soc Exp Biol Med (1976) 0.92
Generic prescribing for epilepsy. Is it safe? Seizure (1996) 0.91
Biological and biochemical characterization of a latent subacute sclerosing panencephalitis (SSPE) virus infection in tissue culture. J Med Virol (1977) 0.90
Isolation, cloning, and complete nucleotide sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II). Virology (2000) 0.89
Measles-virus-specific immunoglobulin-M response in subacute sclerosing panencephalitis. Lancet (1977) 0.89
Transcriptional activation of JC virus by human T-lymphotropic virus type I Tax protein in human neuronal cell lines. J Biol Chem (2000) 0.88
Abnormal levels of antibodies to measles-virus proteins in patient with mental retardation and seizures 24 years after measles encephalitis. Lancet (1979) 0.88
Nucleotide sequence analysis of human T cell leukemia virus, type II (HTLV-II) isolates. AIDS Res Hum Retroviruses (1993) 0.88
Can district-wide audits improve primary care epilepsy management? An audit of seizure frequency recording. Br J Gen Pract (2000) 0.87
Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators. AIDS Res Hum Retroviruses (2000) 0.87
A rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurovirol (1997) 0.87
Detection of HTLV-IIa blood donors in an urban area of the Amazon Region of Brazil (Belém, PA). Rev Soc Bras Med Trop (1998) 0.86
Response. Science (1993) 0.86
Atypical measles syndrome: pathologic and serologic findings. Pediatrics (1982) 0.86
Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med (1991) 0.85
Extraordinary high rate of HTLV type II seropositivity in intravenous drug abusers in south Vietnam. AIDS Res Hum Retroviruses (1995) 0.85
Quantitative studies concerning kaolin edema formation in rats. J Pharmacol Exp Ther (1968) 0.85
Choriocarcinoma in the male patient presenting as gastrointestinal hemorrhage. Am J Surg (1966) 0.85
High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses (1999) 0.84
The effect of cycloheximide on the replication of measles virus. J Gen Virol (1977) 0.84
Slow virus infections of the nervous system: virological, immunological and pathogenetic considerations. J Gen Virol (1978) 0.84
Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes (1994) 0.84
Molecular epidemiology of norovirus strains circulating in Ireland from 2003 to 2004. Epidemiol Infect (2006) 0.83
Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products. J Infect Dis (1994) 0.83
Macrophage Fc receptors control infectivity and neutralization of canine distemper virus-antibody complexes. J Virol (1984) 0.83
Human and bovine xanthine oxidases. Inhibition studies with oxipurinol. Biochem Pharmacol (1986) 0.83
Continued prescribing of inappropriate drugs in general practice. J Clin Pharm Ther (1995) 0.83
Identification of human T cell leukemia virus type IIb infection in the Wayu, an aboriginal population of Colombia. Jpn J Cancer Res (1993) 0.83
Molecular evidence of mother-to-child transmission of HTLV-IIc in the Kararao Village (Kayapo) in the Amazon region of Brazil. Rev Soc Bras Med Trop (2002) 0.83
The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication. J Hum Virol (2001) 0.83
Serological evidence of HTLV-I and HTLV-II coinfections in HIV-1 positive patients in Belém, state of Pará, Brazil. Mem Inst Oswaldo Cruz (1998) 0.82
Imidazo[4,5-c]pyridines (3-deazapurines) and their nucleosides as immunosuppressive and antiinflammatory agents. J Med Chem (1986) 0.82
Antenatal hepatitis B screening - is there a need for a national policy? Ir Med J (2001) 0.81
Polypeptide composition of mumps virus. Med Microbiol Immunol (1977) 0.81
Rupture of the cervical esophagus from blunt trauma. South Med J (1983) 0.80
Origins of HTLV-1 in South America. Nat Med (2000) 0.80
Development of carrageenan pleurisy in the rat: effects of colchicine on inhibition of cell mobilization. Proc Soc Exp Biol Med (1981) 0.79
Functional interaction of HTLV-1 tax protein with the POZ domain of the transcriptional repressor BCL6. Oncogene (2009) 0.79
Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retroviruses (1995) 0.79